Skip to content

Clinical trials

Completed Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Status: Completed Clear all

736 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200021
200115
200211
200317
200419
200527
200621
200725
200833
200923
201027
201125
201222
201328
201428
201528
201625
201751
201851
201943
202048
202134
202226
202318
202412
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed736

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)47
Radiation Therapy Oncology Group18
Dana-Farber Cancer Institute14
Eastern Cooperative Oncology Group13
Groupe Oncologie Radiotherapie Tete et Cou13
M.D. Anderson Cancer Center13
Memorial Sloan Kettering Cancer Center13
Vanderbilt-Ingram Cancer Center11
European Organisation for Research and Treatment of Cancer - EORTC9
Merck Sharp & Dohme LLC9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck736
Head and Neck Neoplasms302
Carcinoma, Non-Small-Cell Lung106
Salivary Gland Neoplasms92
Carcinoma, Squamous Cell58
Melanoma52
Breast Neoplasms48
Esthesioneuroblastoma, Olfactory46
Colorectal Neoplasms43
Tongue Neoplasms43

Trials

Showing 76 to 100 of 736. Each trial links to its page on Pharma Observatory.

636 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.